From the Document: " On May 8, President Trump announced he would be extending the National Guard Title 32 through June 24 to respond to COVID-19 [coronavirus disease 2019]. To date, the President has approved 48 National Guard requests for federal support for the use of National Guard personnel in a Title 32 duty status.  Through this order, the federal government will fund 100 percent of the cost for T-32 [Title 32] National Guard orders through June 24.  On May 9, HHS [U.S. Department of Health and Human Services] announced the allocation plan for the drug remdesivir.  This plan uses a Gilead Sciences, Inc. donation of the drug to the United States.  Gilead Sciences, Inc. will supply approximately 607,000 vials of the experimental drug over the next six weeks."
U.S. Federal Emergency Management Agency: https://www.fema.gov/